Defining HER2-low breast cancer as a clinical subtype

#BREASTPATH Destiny of HER2/neu in the era of HER2-low in 2024Подробнее

Remaining questions on the management of HER2-low breast cancerПодробнее

Living long term with MBC: Making treatment decisionsПодробнее

Is HER2-low a distinct subtype of breast cancer?Подробнее

HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More PatientsПодробнее

The evolution of HER2-low-positive breast cancer as a clinical subtypeПодробнее